A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman Cancer Center in Cleveland has identified the first validated predictive ...

Scottish Labour pledge to tackle ‘gross inequalities’ in cancer screening - The pledge comes ahead of the Holyrood elections ...

Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, focusing on how contemporary therapeutic choices in metastatic hormone-sensitive ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...

Comedian Tommy Cannon has said he was “frightened to death” when he received a prostate cancer diagnosis in his 50s but added that he is “still here, still kicking and doing OK”. The 87-year-old is ...

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...